Authors

    Language

    English

    Publication Date

    10-1-2023

    Journal

    Current Opinion in Structural Biology

    DOI

    10.1016/j.sbi.2023.102647

    PMID

    37399693

    PMCID

    PMC10527939

    PubMedCentral® Posted Date

    10-1-2024

    PubMedCentral® Full Text Version

    Author MSS

    Abstract

    Polymyxins, a last resort antibiotic, target the outer membrane of pathogens and are used to address the increasing prevalence of multidrug-resistant Gram-negative bacteria. The plasmid-encoded enzyme MCR-1 confers polymyxin resistance to bacteria by modifying the outer membrane. Transferable resistance to polymyxins is a major concern; therefore, MCR-1 is an important drug target. In this review, we discuss recent structural and mechanistic aspects of MCR-1 function, its variants and homologs, and how they are relevant to polymyxin resistance. Specifically, we discuss work on polymyxin-mediated disruption of the outer and inner membranes, computational studies on the catalytic mechanism of MCR-1, mutagenesis and structural analysis concerning residues important for substrate binding in MCR-1, and finally, advancements in inhibitors targeting MCR-1.

    Keywords

    Polymyxins, Colistin, Escherichia coli Proteins, Drug Resistance, Bacterial, Anti-Bacterial Agents, Biology

    Published Open-Access

    yes

    Share

    COinS
     
     

    To view the content in your browser, please download Adobe Reader or, alternately,
    you may Download the file to your hard drive.

    NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.